Global Biopharmaceutical Excipients Market 2023-2029

March 2023 | 78 pages | ID: GFECED6E945CEN
Gen Consulting Company

Abstracts

Biopharmaceutical excipients are substances, other than the active pharmaceutical ingredient (API), that are added to a biopharmaceutical drug product to enhance its stability, safety, and efficacy. These substances can interact with the API or with other excipients, influencing the physical and chemical properties of the formulation, the drug delivery system, and the bioavailability of the drug. The global biopharmaceutical excipients market is likely to register a CAGR of over 7.81% with an incremental growth of USD 1.3 billion during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global biopharmaceutical excipients market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the excipient, biologics, scale of operation, end user, and region. The global market for biopharmaceutical excipients can be segmented by excipient: bulking agents, solubilizers & surfactants, buffering & tonicity agents, others. The bulking agents segment held the largest share of the global biopharmaceutical excipients market in 2022 and is anticipated to hold its share during the forecast period. Biopharmaceutical excipients market is further segmented by biologics: monoclonal antibodies, vaccines, others. Globally, the monoclonal antibodies segment made up the largest share of the biopharmaceutical excipients market. Based on scale of operation, the biopharmaceutical excipients market is segmented into: commercial, research. The commercial segment was the largest contributor to the global biopharmaceutical excipients market in 2022. On the basis of end user, the biopharmaceutical excipients market also can be divided into: pharma & biotech companies, cmos & cdmos, academic & research institutes, others. The pharma & biotech companies segment is estimated to account for the largest share of the global biopharmaceutical excipients market. Biopharmaceutical excipients market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By excipient: bulking agents, solubilizers & surfactants, buffering & tonicity agents, others
By biologics: monoclonal antibodies, vaccines, others
By scale of operation: commercial, research
By end user: pharma & biotech companies, cmos & cdmos, academic & research institutes, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading biopharmaceutical excipients market vendors that include Merck KGaA, Avantor Inc., BASF SE, Evonik Industries AG, Roquette Fr?res SA, Associated British Foods plc, Ashland Global Holdings Inc., Clariant AG, Fuji Chemical Industry Co., Ltd., Dow Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global biopharmaceutical excipients market.
To classify and forecast the global biopharmaceutical excipients market based on excipient, biologics, scale of operation, end user, region.
To identify drivers and challenges for the global biopharmaceutical excipients market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biopharmaceutical excipients market.
To identify and analyze the profile of leading players operating in the global biopharmaceutical excipients market.

Why Choose This Report
Gain a reliable outlook of the global biopharmaceutical excipients market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY EXCIPIENT

Bulking agents
Solubilizers & surfactants
Buffering & tonicity agents
Others

PART 6. MARKET BREAKDOWN BY BIOLOGICS

Monoclonal antibodies
Vaccines
Others

PART 7. MARKET BREAKDOWN BY SCALE OF OPERATION

Commercial
Research

PART 8. MARKET BREAKDOWN BY END USER

Pharma & biotech companies
Cmos & cdmos
Academic & research institutes
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Merck KGaA
Avantor Inc.
BASF SE
Evonik Industries AG
Roquette Fr?res SA
Associated British Foods plc
Ashland Global Holdings Inc.
Clariant AG
Fuji Chemical Industry Co., Ltd.
Dow Inc.

DISCLAIMER